Hind.Organ.Chem. Q1 FY27 Results (BSE: 500449)
Signal: Loss reversed
The read
The key inflection is a return to positive consolidated PAT of ₹383.98 lakh from a ₹621.95 lakh loss, driven by gross-margin expansion to 42.1% from 6.2%; however, revenue fell 29.53% YoY, other income of ₹429.34 lakh exceeded PBT, and the prior Kochi shutdown/restructuring history makes the sustainability of the margin recovery uncertain.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹96 Cr | -29.53% | -41.42% |
| EBIT | ₹8.65 Cr | N/A | |
| Net profit | ₹3.84 Cr | N/M (loss to profit) | |
| EPS | ₹0.57 | N/M (loss to profit) | |
| EBIT margin | 9.5% |
P&L walk
Revenue declined 29.53% YoY to ₹9,599.62 lakh, while gross margin expanded to 42.1% from 6.2% as raw-material cost fell to 71.2% of revenue from 88.4%; EBITDA margin was 9.5%, but PAT of ₹383.98 lakh was supported by other income of ₹429.34 lakh, equal to 116.3% of PBT.
Key positives
- Consolidated PAT recovered to ₹383.98 lakh from a ₹621.95 lakh loss in Q1FY26, while EPS improved to ₹0.57 from ₹-0.95.
- Gross margin expanded to 42.1% from 6.2% as raw-material cost fell to 71.2% of revenue from 88.4%, a 3,590bps YoY tailwind.
- Kochi Phenol plant is stated to be operational, while the company continues implementing the government-approved restructuring plan.
Key concerns
- Revenue declined 29.53% YoY to ₹9,599.62 lakh and 41.42% sequentially, with no volume or realisation disclosure to demonstrate demand recovery.
- The gross-margin improvement is not explained by management and may be transient; raw-material cost fell 43.32% YoY while revenue fell 29.53%.
- Other income of ₹429.34 lakh represented 116.3% of PBT, so the ₹383.98 lakh PAT does not solely reflect recurring operating earnings.
Earnings quality: includes non-operating other income
Research and educational content only. Not investment advice.